David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.15% |
| 2 | Consumer Discretionary | 12.62% |
| 3 | Healthcare | 10.65% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JWN
3051
CALL
DELISTED
Nordstrom
JWN
| $518K | ﹤0.01% |
10,000
| – | – |
|
|
CYBR
3052
CALL
DELISTED
CyberArk
CYBR
| $516K | ﹤0.01% |
+8,200
| New | +$479K |
|
3053
CorVel
CRVL
$3.6B
| $515K | ﹤0.01% |
28,617
-7,548
| -21% | -$130K |
|
|
ALE
3054
DELISTED
Allete
ALE
| $514K | ﹤0.01% |
6,640
-10,581
| -61% | -$792K |
|
3055
CALL
Allegiant Air
ALGT
$2.23B
| $514K | ﹤0.01% |
3,700
| – | – |
|
|
SMTA
3056
DELISTED
Spirit MTA REIT Common Shares of Beneficial Interest
SMTA
| $514K | ﹤0.01% |
+49,891
| New | +$497K |
|
3057
Ionis Pharmaceuticals
IONS
$10.3B
| $513K | ﹤0.01% |
12,300
-12,462
| -50% | -$552K |
|
3058
PUT
Red Rock Resorts
RRR
$3.59B
| $513K | ﹤0.01% |
15,300
| – | – |
|
3059
CALL
GSK
GSK
$104B
| $512K | ﹤0.01% |
10,160
-24,000
| -70% | -$1.21M |
|
3060
PUT
Kimco Realty
KIM
$16.2B
| $510K | ﹤0.01% |
30,000
| – | – |
|
|
ONC
3061
BeOne Medicines Ltd
ONC
$42.1B
| $510K | ﹤0.01% |
+3,318
| New | +$592K |
|
3062
DXP Enterprises
DXPE
$2.9B
| $509K | ﹤0.01% |
13,333
-1,138
| -8% | -$43.8K |
|
3063
PUT
Teck Resources
TECK
$34.4B
| $509K | ﹤0.01% |
20,000
| – | – |
|
|
ESPR
3064
PUT
DELISTED
Esperion Therapeutics
ESPR
| $506K | ﹤0.01% |
+12,900
| New | +$652K |
|
3065
Gorman-Rupp
GRC
$2.06B
| $506K | ﹤0.01% |
14,452
+4,849
| +50% | +$158K |
|
3066
PUT
Dana Inc
DAN
$3.24B
| $505K | ﹤0.01% |
+25,000
| New | +$594K |
|
3067
Invesco Mortgage Capital
IVR
$805M
| $503K | ﹤0.01% |
+3,161
| New | +$513K |
|
3068
Precigen
PGEN
$2.57B
| $503K | ﹤0.01% |
36,042
-67,156
| -65% | -$1.13M |
|
3069
PUT
Hyatt Hotels
H
$17B
| $501K | ﹤0.01% |
6,500
-6,400
| -50% | -$509K |
|
3070
Saic
SAIC
$5.36B
| $501K | ﹤0.01% |
6,195
+3,495
| +129% | +$297K |
|
3071
PUT
BHP
BHP
$247B
| $500K | ﹤0.01% |
11,210
| – | – |
|
3072
CALL
Natural Health Trends
NHTC
$15M
| $500K | ﹤0.01% |
20,000
| – | – |
|
|
3073
PUT
Natural Health Trends
NHTC
$15M
| $500K | ﹤0.01% |
20,000
| – | – |
|
|
HSKA
3074
DELISTED
Heska Corp
HSKA
| $500K | ﹤0.01% |
4,820
-857
| -15% | -$80.2K |
|
3075
Sierra Bancorp
BSRR
$514M
| $499K | ﹤0.01% |
17,682
+2,754
| +18% | +$77.7K |
|
Similar funds
David Shaw's Q2 2018 Portfolio in Review
As of Q2 2018, David Shaw held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- David Shaw added most to Amazon in Q2 2018, an estimated $696M increase.
- David Shaw's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- David Shaw fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- David Shaw's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- David Shaw opened 622 new positions and closed 399 in Q2 2018.
- David Shaw's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.